The present and future burden of previously treated advanced non-small cell lung cancer (NSCLC) by histology and line of therapy in France, Germany, Italy, and Spain: model-based predictions-Reference-Cited by-同舟云学术

The present and future burden of previously treated advanced non-small cell lung cancer (NSCLC) by histology and line of therapy in France, Germany, Italy, and Spain: model-based predictions

Published:2018-11-26 Issue:1 Volume:16 Page:
ISSN:1478-7954
Container-title:Population Health Metrics
language:en
Short-container-title:Popul Health Metrics

Author:

Campbell David^ORCID,O’Day Ken,Hertel Nadine,Penrod John R.,Manley Daumont Melinda,Lees Michael

Funder

Bristol-Myers Squibb Pharmaceuticals Ltd

Publisher

Springer Science and Business Media LLC

Subject

Public Health, Environmental and Occupational Health,Epidemiology

Link

http://link.springer.com/content/pdf/10.1186/s12963-018-0174-4.pdf

Reference38 articles.

1. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide: IARC Cancer Base no. 11. Lyon: International Agency for Research on Cancer; 2013. http://globocan.iarc.fr . Accessed 18 Nov 2015

2. GLOBOCAN. Fact sheets by population. 2012. http://gco.iarc.fr/today/fact-sheets-populations . Accessed 23 Nov 2015.

3. Cancer Research UK. Lung cancer incidence. 2014. http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/lung-cancer/incidence#geog . Accessed 14 Feb 2016.

4. Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA. Non–small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc Mayo Clin. 2008;83(5):584–94.

5. NCCN. Clinical practice guidelines in oncology. Non-small cell lung cancer. Version 3.2017. 2017. https://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf . Accessed 22 May 2017.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metastatic non-small-cell lung cancer without driver mutations: projections by therapy line in Western Europe, 2021–2026;Future Oncology;2023-10

2. Mendelian randomization study of interleukin (IL)-1 family and lung cancer;Scientific Reports;2021-09-02